Biomea Fusion Inc
Biomea Fusion Inc (BMEA) Covered Calls
As of September 15, 2026, BMEA has 9 covered call opportunities in the coming three months. Return ranges from 17.8 to 333.9% until expiration. Annualized return ranges from 15.2 to 551.1%. The nearest expiration is October 16, 2026. Maximum potential profit is $581.
Read more
Running BMEA covered calls helps you generate consistent income from Biomea Fusion Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Biomea Fusion Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best BMEA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if BMEA stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling BMEA covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Biomea Fusion Inc covered call is worth writing.
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.
Income-focused investors, long-term BMEA holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling BMEA covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Biomea Fusion Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile41.67% Neutral
- Market cap (M$)130
- 52 weeks high-39.80%
- 52 weeks low106.90%
- Analyst recommendationStrong Buy
1.50 - Target price$6.71
272.78% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E—
- EPS (ttm)-0.50
- EPS growth next 5 years12.54%
As of September 15, 2026
| 2027-01-15 | 126 | 5.00 | 187.36 | 0.05 | 0.15 | 331.00 | 190.23 | 551.06 | -2.87 | +0.18 | 1,421 | 0.10 |
| 2026-10-16 | 35 | 2.50 | 43.68 | 0.05 | 0.15 | 81.00 | 46.55 | 485.47 | -2.87 | +0.27 | 29,318 | 0.10 |
| 2028-01-21 | 497 | 7.50 | 331.03 | 0.05 | 4.90 | 581.00 | 333.91 | 245.22 | -2.87 | +1.00 | 105 | 4.85 |
| 2027-01-15 | 126 | 2.50 | 43.68 | 0.20 | 0.40 | 96.00 | 55.17 | 159.82 | -11.49 | +0.46 | 12,885 | 0.20 |
| 2028-01-21 | 497 | 5.00 | 187.36 | 0.40 | 0.55 | 366.00 | 210.34 | 154.48 | -22.99 | +0.49 | 7,162 | 0.15 |
| 2028-01-21 | 497 | 3.00 | 72.41 | 0.30 | 1.05 | 156.00 | 89.66 | 65.84 | -17.24 | +0.63 | 621 | 0.75 |
| 2028-01-21 | 497 | 2.50 | 43.68 | 0.55 | 0.95 | 131.00 | 75.29 | 55.29 | -31.61 | +0.68 | 11,783 | 0.40 |
| 2027-01-15 | 126 | 2.00 | 14.94 | 0.05 | 0.75 | 31.00 | 17.82 | 51.61 | -2.87 | +0.57 | 1,121 | 0.70 |
| 2028-01-21 | 497 | 2.00 | 14.94 | 0.10 | 2.20 | 36.00 | 20.69 | 15.19 | -5.75 | +0.83 | 513 | 2.10 |
As of September 15, 2026
Sell covered calls with the data behind you
Find the best BMEA covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→